About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.
ACADIA Pharmaceuticals Inc. (ACAD) Stock Score & Signals
ACADIA Pharmaceuticals Inc. (ACAD) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 56 out of 100.
2BB score and signals
ACADIA Pharmaceuticals Inc.’s current 2BB score is 56 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 68 | High |
| Momentum | 49 | Stable |
| Financial strength | 69 | Strong |
| Quality | 98 | Very Strong |
| Risk | 13 | Very Low |
Company facts
| CEO | Catherine Owen Adams |
| Headquarters | San Diego, California, United States |
| Founded | 1993 |
| Employees | 797 |
| P/E ratio | 8.70 |
| 52-week range | $18.39 – $30.96 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-23 | — | 0.2223 | — | $369.52M |
| 2026-11-03 | — | 0.1982 | — | $338.15M |
| 2026-08-04 | — | 0.0586 | — | $301.77M |
| 2026-05-06 | 0.02 | 0.0633 | $268.06M | $286.32M |